1、 FERRANDINA G, RANELLETTI FO, LEGGE F, et al. Prognostic role of the ratio between cyclooxygenase-2 in tumor and stroma compartmentsin cervical cancer[J]. Clin Cancer Res, 2004,10(9):3117-3123. FERRANDINA G, RANELLETTI FO, LEGGE F, et al. Prognostic role of the ratio between cyclooxygenase-2 in tumor and stroma compartmentsin cervical cancer[J]. Clin Cancer Res, 2004,10(9):3117-3123.
2、 NAGAI G, KANELLETTI FO, LEGGE F, et al. Cyelooxygenase-2(COX-2) expression in locally advanced cervical cancer patients undergoing chemoradiation plus surgery. Int J Radiat Oncol Biol Phys, 2003,55(l):21-27. NAGAI G, KANELLETTI FO, LEGGE F, et al. Cyelooxygenase-2(COX-2) expression in locally advanced cervical cancer patients undergoing chemoradiation plus surgery. Int J Radiat Oncol Biol Phys, 2003,55(l):21-27.
3、 黄艳,金淑静,柳红,等. P-gp和Bcl-2在大肠癌中的表达及相关性的研究[J]. 广州医药,2004,35(2):6-9. 黄艳,金淑静,柳红,等. P-gp和Bcl-2在大肠癌中的表达及相关性的研究[J]. 广州医药,2004,35(2):6-9.
4、 SZOSTAK M, KAUR P, AMIN P, et al. Apoptosis and bcl-2 expression inprostate cancer significance in clinical outcome after brachytherapy[J]. J Urol, 2001,165(6 Pt 1):2126-2130. SZOSTAK M, KAUR P, AMIN P, et al. Apoptosis and bcl-2 expression inprostate cancer significance in clinical outcome after brachytherapy[J]. J Urol, 2001,165(6 Pt 1):2126-2130.
5、 SCHMITT CA, ROSENTHAL CT, LOWE SW. Genetic analysis of chemoresistance in primary murine lymphomas[J]. Nat Med, 2000,6(9):1029-1035. SCHMITT CA, ROSENTHAL CT, LOWE SW. Genetic analysis of chemoresistance in primary murine lymphomas[J]. Nat Med, 2000,6(9):1029-1035.
6、 张琦,许进琼.环氧合酶-2及核因子-κB在宫颈癌组织中的表达及意义[J]. 现代医药卫生,2009,25(6):2417-2418. 张琦,许进琼.环氧合酶-2及核因子-κB在宫颈癌组织中的表达及意义[J]. 现代医药卫生,2009,25(6):2417-2418.
7、 DEMPKE W, RIE C, et al. Cyclooxygenase-2: a novel target for cancer chemotherapy[J]. Cancer Res Oncol,2001,127(7):411-417. DEMPKE W, RIE C, et al. Cyclooxygenase-2: a novel target for cancer chemotherapy[J]. Cancer Res Oncol,2001,127(7):411-417.
8、 陆俊国,杨磊,谭清和,等.非小细胞肺癌组织COX-2和HER-2表达及其临床意义[J]. 中华肿瘤防治杂志,2010,17(3):206-212. 陆俊国,杨磊,谭清和,等.非小细胞肺癌组织COX-2和HER-2表达及其临床意义[J]. 中华肿瘤防治杂志,2010,17(3):206-212.
9、 刘美兰,李乐云.COX-2和mPGEs-1与肿瘤关系的研究进展[J]. 中华肿瘤防治杂志,2010,17(14):1134-1137. 刘美兰,李乐云.COX-2和mPGEs-1与肿瘤关系的研究进展[J]. 中华肿瘤防治杂志,2010,17(14):1134-1137.
10、 PROTRKA Z, ARSENIJEVIC S, et al. Co-overexpression of bcl-2 and c-myc in uterine cervix carcinomas and premalignant lesions[J]. Eur J Histochem, 2011,55(1):44-49. PROTRKA Z, ARSENIJEVIC S, et al. Co-overexpression of bcl-2 and c-myc in uterine cervix carcinomas and premalignant lesions[J]. Eur J Histochem, 2011,55(1):44-49.
11、 朱华,施铮铮. Survivin、Bcl-2、HPV 16/18 在宫颈上皮内瘤变及 宫颈癌中的表达及临床意义[J]. 实用妇产科杂志,2010,26(1):57-60. 朱华,施铮铮. Survivin、Bcl-2、HPV 16/18 在宫颈上皮内瘤变及 宫颈癌中的表达及临床意义[J]. 实用妇产科杂志,2010,26(1):57-60.
12、 ZHOU XL, WANG M. Expression levels of survivin, Bcl-2, and KAI1 proteins in cervical cancer and their correlation with metastasis[J]. Genet Mol Res, 2015,14(4):17059-17067. ZHOU XL, WANG M. Expression levels of survivin, Bcl-2, and KAI1 proteins in cervical cancer and their correlation with metastasis[J]. Genet Mol Res, 2015,14(4):17059-17067.
13、 林悦欢,何慧仪.检测Bcl-2、COX-2在宫颈病变诊断中的可行性研究[J]. 中国妇幼保健,2013,28(28):4618-4620. 林悦欢,何慧仪.检测Bcl-2、COX-2在宫颈病变诊断中的可行性研究[J]. 中国妇幼保健,2013,28(28):4618-4620.
14、 林仲秋,王丽娟.国际妇产科联盟2012宫颈癌诊治指南解读[S]. 中国实用妇科与产科杂志,2013,29(5):323-325. 林仲秋,王丽娟.国际妇产科联盟2012宫颈癌诊治指南解读[S]. 中国实用妇科与产科杂志,2013,29(5):323-325.
15、 LEI T, MAO WM, LEI TH, et al. Incidence and mortality trend of cervical cancer in 11 cancer registries of China[J]. Chin J Cancer Res, 2011, 23(1):10-14. LEI T, MAO WM, LEI TH, et al. Incidence and mortality trend of cervical cancer in 11 cancer registries of China[J]. Chin J Cancer Res, 2011, 23(1):10-14.
16、 杨炜敏,袁力,何善阳,等.KAI1 转移抑制基因在宫颈鳞癌中的表达及临床意义[J]. 广州医药,2009,40(4):25-27. 杨炜敏,袁力,何善阳,等.KAI1 转移抑制基因在宫颈鳞癌中的表达及临床意义[J]. 广州医药,2009,40(4):25-27.
17、 谢幸,苟文丽.妇产科学(第8版)[M]. 北京:人民卫生出版社,2013.304. 谢幸,苟文丽.妇产科学(第8版)[M]. 北京:人民卫生出版社,2013.304.
